Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT01689987 · COMPLETED

Trial details

NCT number: NCT01689987
Sponsor: OHSU Knight Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Start date: 2012-09-01
Primary completion: 2016-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.